Unrelated cord blood transplantation in pediatric patients: A report from Saudi Arabia

Bone Marrow Transplantation

Volumn 45, Issue 8, 2010, Pages 1281-1286

  Ayas, M ^a   Al Seraihi, A ^a   Al Jefri, A ^a   Al Ahmari, A ^a   Al Mahr, M ^a   Al Ghonaium, A ^a   Al Muhsen, S ^a,b   Al Mousa, H ^a   Al Dhekri, H ^a   Alsaud, B ^a   Eldali, A ^a   Mohamad, A ^a   Al Humaidan, H ^a   Chadrawi, A ^a   Al Kaff, M ^a   Al Hassnan, Z ^a   El Solh, H ^a  

^a KING FAISAL SPECIALIST HOSPITAL AND RESEARCH CENTER   (Saudi Arabia)

^b KING SAUD UNIVERSITY   (Saudi Arabia)

Author keywords

antithymocyte globulin; cord blood transplantation; Ethnicity; graft failure; TBI

Indexed keywords

CYCLOPHOSPHAMIDE; FLUDARABINE; MELPHALAN; THYMOCYTE ANTIBODY;

ACUTE BIPHENOTYPIC LEUKEMIA; ACUTE GRAFT VERSUS HOST DISEASE; ACUTE GRANULOCYTIC LEUKEMIA; ACUTE LYMPHOCYTIC LEUKEMIA; ARTICLE; BONE MARROW DEPRESSION; CELL VIABILITY; CHILD; CHRONIC GRAFT VERSUS HOST DISEASE; CONTROLLED STUDY; CORD BLOOD STEM CELL TRANSPLANTATION; CYTOMEGALOVIRUS INFECTION; ENGRAFTMENT; EVENT FREE SURVIVAL; FEMALE; HEMATOLOGIC DISEASE; HEMATOPHAGOCYSTIC SYNDROME; HEMORRHAGIC CYSTITIS; HLA MATCHING; HUMAN; IMMUNE DEFICIENCY; INFANT; MAJOR CLINICAL STUDY; MALE; METABOLIC DISORDER; MYELODYSPLASTIC SYNDROME; NONHODGKIN LYMPHOMA; OVERALL SURVIVAL; PRIORITY JOURNAL; REDUCED INTENSITY CONDITIONING; SAUDI ARABIA; SCHOOL CHILD; SICKLE CELL ANEMIA; VEIN OCCLUSION;

BLOOD BANKS; BLOOD DONORS; CHILD; CHILD, PRESCHOOL; CORD BLOOD STEM CELL TRANSPLANTATION; ETHNIC GROUPS; FEMALE; GENETIC DISEASES, INBORN; GRAFT SURVIVAL; GRAFT VS HOST DISEASE; HEMATOLOGIC DISEASES; HISTOCOMPATIBILITY TESTING; HUMANS; INFANT; INTERNATIONAL COOPERATION; MALE; SAUDI ARABIA; TRANSPLANTATION IMMUNOLOGY;

EID: 77955580712     PISSN: 02683369     EISSN: 14765365     Source Type: Journal    
DOI: 10.1038/bmt.2009.350     Document Type: Article

References (31)

1. Yoshimi A, Kojima S, Taniguchi S, Hara J, Matsui T, Takahashi Y et al. Unrelated cord blood transplantation for severe aplastic anemia. Biol Blood Marrow Transplant 2008; 14: 1057-1063.
2. Pinto FO, Roberts I. Cord blood stem cell transplantation for haemoglobinopathies. Br J Haematol 2008; 141: 309-324.
3. Gluckman E, Rocha V, Ionescu I, Bierings M, Harris R, Wagner J et al. Results of unrelated cord blood transplant in Fanconi anemia patients: risk factor analysis for engraft- ment and survival. Biol Blood Marrow Transplant 2007; 13: 1073-1082.
4. Diaz de Heredia C, Ortega JJ, Diaz MA, Olive T, Badell I, Gonzalez-Vicent M et al. Unrelated cord blood transplantation for severe combined immunodeficiency and other primary immunodeficiencies. Bone Marrow Transplant 2008; 41: 627-633.
5. Tsuji Y, Imai K, Kajiwara M, Aoki Y, Isoda T, Tomizawa D et al. Hematopoietic stem cell transplantation for 30 patients with primary immunodeficiency diseases: 20 years experience of a single team. Bone Marrow Transplant 2006; 37: 469-477.
6. Sawczyn KK, Quinones R, Malcolm J, Foreman N, Garrington T, Gore L et al. Cord blood transplant in childhood ALL. Pediatr Blood Cancer 2005; 45: 964-1670
7. Isoyama K, Oda M, Kato K, Nagamura-Inoue T, Kai S, Kigasawa H et al. Long-term outcome of cord blood transplantation from unrelated donors as an initial transplantation procedure for children with AML in Japan. Bone Marrow Transplant 2009; (e-pub ahead of print).
8. Wall DA, Carter SL, Kernan NA, Kapoor N, Kamani NR, Brochstein JA et al. Busulfan/melphalan/antithymocyte globulin followed by unrelated donor cord blood transplantation for treatment of infant leukemia and leukemia in young children: the Cord Blood Transplantation study (COBLT) experience. Biol Blood Marrow Transplant 2005; 11: 637-646.
9. Barker JN, Rocha V, Scaradavou A. Optimizing unrelated donor cord blood transplantation. Biol Blood Marrow Transplant 2008; 15: 154-161.
10. Wall DA, Chan KW. Selection of cord blood unit(s) for transplantation. Bone Marrow Transplant 2008; 42: 1-7.
11. Novelo-Garza B, Limon-Flores A, Guerra-Marquez A, Luna- Bautista F, Juan-Shum L, Montero I et al. Establishing a cord blood banking and transplantation program in Mexico: a single institution experience. Transfusion 2008; 48: 228-236.
12. Wu JY, Liao C, Xu ZP, Chen JS, Gu SL, Huang YN et al. Banking and transplantation of umbilical cord blood in Guangzhou, China. Cytotherapy 2006; 8: 488-497.
13. Mugishima H, Takahashi T, Nagamura T, Asano S, Saito H. Umbilical cord blood for unrelated bone marrow replacement; Asia bank and Japan cord blood bank network update. Int J Hematol 2002; 76(Suppl 2): 284-286.
14. Meyer-Monard S, Passweg J, Troeger C, Eberhard H-P, Roosnek E, Nicoloso de Faveri G et al. Cord blood banks collect units with different HLA alleles and haplotypes to volunteer donor banks: a comparative report from Swiss Blood stem cells. Bone Marrow Transplant 2009; 43: 771-778.
15. Rocha V, Cornish J, Sievers EL, Filipovich A, Locatelli F, Peters C et al. Comparison of outcomes of unrelated bone marrow and umbilical cord blood transplants in children with acute leukemia. Blood 2001; 97: 2962-2967.
16. Long GD, Laughlin M, Madan B, Kurtzberg J, Gasparetto C, Morris A et al. Unrelated umbilical cord blood transplantation in adult patients. Biol Blood Marrow Transplant 2003; 9: 772-780.
17. Knutsen AP, Wall DA. Umbilical cord blood transplantation in severe T-cell immunodeficiency disorders: two-year experience. J Clin Immunol 2000; 20: 466-476.
18. Majhail NS, Brunstein CG, Tomblyn M, Thomas AJ, Miller JS, Arora M et al. Reduced-intensity allogeneic transplant in patients older than 55 years: unrelated umbilical cord blood is safe and effective for patients without a matched related donor. Biol Blood Marrow Transplant 2008; 14: 282-289.
19. Bradley MB, Satwani P, Baldinger L, Morris E, van de Ven C, Del Toro G et al. Reduced intensity allogeneic umbilical cord blood transplantation in children and adolescent recipients with malignant and non-malignant diseases. Bone Marrow Transplant 2007; 40: 621-631.
20. Rocha V, Mohty M, Gluckman E, Rio B. Reduced-intensity conditioning regimens before unrelated cord blood transplantation in adults with acute leukaemia and other haematological malignancies. Curr Opin Oncol 2009; 21(Suppl 1): S31-S34.
21. Awaya T, Kato T, Niwa A, Hiramatsu H, Umeda K, Watanabe KI et al. Successful cord blood transplantation using a reduced-intensity conditioning regimen for advanced childhood-onset cerebral adrenoleukodystrophy. Pediatr Transplant 2009; (e-pub ahead of print).
22. MacMillan ML, Weisdorf DJ, Brunstein CG, Cao Q, DeFor TE, Verneris MR et al. Acute graft-versus-host disease after unrelated donor umbilical cord blood transplantation: analysis of risk factors. Blood 2009; 113: 2410-2415.
23. Laughlin MJ, Barker J, Bambach B, Koc ON, Rizzieri DA, Wagner JE et al. Hematopoietic engraftment and survival in adult recipients of umbilical-cord blood from unrelated donors. N Engl J Med 14; 344: 1815-1822.
24. Wagner JE, Barker JN, DeFor TE, Baker KS, Blazar BR, Eide C et al. Transplantation of unrelated donor umbilical cord blood in 102 patients with malignant and nonmalignant diseases: influence of CD34 cell dose and HLA disparity on treatment-related mortality and survival. Blood 2002; 100: 1611-1618.
25. Rubinstein P, Carrier C, Scaradavou A, Kurtzberg J, Adamson J, Migliaccio AR et al. Outcomes among 562 recipients of placental-blood transplants from unrelated donors. N Engl J Med 1998; 339: 1565-1577.
26. Gluckman E, Rocha V, Boyer-Chammard A, Locatelli F, Arcese W, Pasquini R et al. Outcome of cord-blood transplantation from related and unrelated donors. Eurocord Transplant Group and the European Blood and Marrow Transplantation Group. N Engl J Med 1997; 337: 373-381.
27. Shimada K, Narimatsu H, Morishita Y, Kohno A, Saito S, Kato Y. Severe regimen-related toxicity of second transplantation for graft failure following reduced-intensity cord blood transplantation in an adult patient. Bone Marrow Transplant 2006; 37: 787-788.
28. Mizutani E, Narimatsu H, Murata M, Tomita A, Kiyoi H, Naoe T. Successful second cord blood transplantation using fludarabine and cyclophosphamide as a preparative regimen for graft rejection following reduced-intensity cord blood transplantation. Bone Marrow Transplant 2007; 40: 85-87. (Pubitemid 47018419)
29. Isoyama K, Ohnuma K, Ikuta K, Toyoda Y, Nakajima F, Yamada K et al. Unrelated cord blood transplantation for second hemopoietic stem cell transplantation. Pediatr Int 2003; 45: 268-274.
30. Ohwada C, Nakaseko C, Ozawa S, Takeuchi M, Shono K, Koizumi M et al. Second cord blood transplantation (CBT) with reduced-intensity conditioning for graft failure after the first CBT for AML. Bone Marrow Transplant 2004; 34: 999-1000.
31. Ayas M, Al-Jefri A, Al-Seraihi A, Al-Mahr M, Al-Ahmari A, El-Solh H. Second stem cell transplantation in patients with Fanconi anemia using antithymocyte globulin alone for conditioning. Biol Blood Marrow Transplant 2008; 14: 445-448.